ARCA:BBC
Virtus LifeSci Biotech Clinical Trials ETF | |
$ 29.7 0.5231 ( +1.79%) 04:00 PM EST | |
PE Ratio:
27.86
PB Ratio:
0.13
Volume:
1.73K
Dividend Yield %:
0.28
| |
Last Holding update 2024-09-27 | 121 Stocks (34 new) |
Value $11.00 Mil | Turnover 37 % |
Portfolio Report | |
Registrant: ETFis Series Trust I
|
Performance
Dividend
Log
Bar
Annualized Return %
Total Annual Return %
Key Statistics
Name | Value | ||
---|---|---|---|
Day's Open ($) | 29.54 | ||
Day's Range ($) | 29.54 - 29.89 | ||
Day's Volume | 1,730 | ||
52-Week Range ($) | 16.91 - 31.99 | ||
Beta | 0.94 | ||
Volatility | 38.33 | ||
14-Day RSI | 53.47 | ||
14-Day ATR ($) | 0.497054 | ||
20-Day SMA ($) | 28.77114 |
Fundamental Data
Name | Value | ||
---|---|---|---|
Market Cap (Mil $) | 11.88 | ||
Shares Outstanding (Mil) | 0.4 | ||
PE Ratio | 27.86 | ||
PE Ratio (10y Range) | 8.62 - 98.44 | ||
PE Ratio (10y Median) | 14.68 | ||
PB Ratio | 0.13 | ||
PB Ratio (10y Range) | 0.13 - 5.36 | ||
PB Ratio (10y Median) | 3.93 |
Dividend Data
Name | Value | ||
---|---|---|---|
Dividends per Share (TTM) ($) | 0.082 | ||
Dividend Yield % | 0.28 | ||
Dividend Yield % (10y Range) | 0.26 - 1.29 | ||
Dividend Yield % (10y Median) | 0.34 | ||
Next Dividend Payment Date | |||
Dividend Frequency | Annually |
BBC Virtus LifeSci Biotech Clinical Trials ETF Fundamental Charts
Historical TTM Price-to-Earnings for BBC Virtus LifeSci Biotech Clinical Trials ETF
Historical TTM Price-to-Earnings without NRI for BBC Virtus LifeSci Biotech Clinical Trials ETF
Historical Price-to-Book Ratio for BBC Virtus LifeSci Biotech Clinical Trials ETF
Historical Dividend Yields for BBC Virtus LifeSci Biotech Clinical Trials ETF
BBC Virtus LifeSci Biotech Clinical Trials ETF Technical Indicators
Moving Average
Momentum
Gurus Latest Trades with ARCA:BBC
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
ARCA:BBC is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Virtus LifeSci Biotech Clinica... Top Holdings of 2024-07-31
View Full List
Ticker | | Company | Shares | Value ($1000) | Shares Change % | Weighting % | Trade Impact % | % of Shares outstanding | 3M Change % | YTD Change % | Market Cap $Mil | Industry |
---|---|---|---|---|---|---|---|---|---|---|---|---|
MORF | Morphic Holding Inc | 3,262 | 184.820 | +11.14% | 1.630 | +0.16% | 0.010 | +88.50% | +97.32% | 2862.305 | Biotechnology | |
LBPH | Longboard Pharmaceuticals Inc | 4,538 | 150.840 | New Holding | 1.330 | +1.33% | 0.010 | +59.57% | +889.72% | 2329.253 | Biotechnology | |
QURE | uniQure NV | 17,243 | 132.080 | +61.26% | 1.170 | +0.44% | 0.040 | -19.86% | -1.33% | 325.300 | Biotechnology | |
ORIC | ORIC Pharmaceuticals Inc | 11,787 | 132.010 | +24.90% | 1.170 | +0.23% | 0.020 | -28.99% | -8.15% | 596.084 | Biotechnology | |
ERAS | Erasca Inc | 41,526 | 130.810 | New Holding | 1.150 | +1.15% | 0.010 | -19.22% | +24.39% | 748.495 | Biotechnology | |
PRAX | Praxis Precision Medicines Inc | 2,260 | 130.420 | New Holding | 1.150 | +1.15% | 0.010 | +24.34% | +221.95% | 1273.715 | Biotechnology | |
ANAB | AnaptysBio Inc | 3,733 | 130.060 | -17.97% | 1.150 | -0.20% | 0.010 | -17.73% | +42.34% | 920.792 | Biotechnology | |
IGMS | IGM Biosciences Inc | 11,401 | 127.240 | -14.48% | 1.120 | -0.18% | 0.020 | +59.48% | +114.56% | 1057.652 | Biotechnology | |
SLRN | Acelyrin Inc | 20,763 | 124.580 | +74.46% | 1.100 | +0.47% | 0.020 | -10.29% | -15.82% | 626.796 | Biotechnology | |
SMMT | Summit Therapeutics Inc | 11,190 | 120.850 | -65.90% | 1.070 | -0.84% | 0.000 | +92.55% | +752.11% | 16343.957 | Biotechnology |
Virtus LifeSci Biotech Clinical Trials ETF's Historical Top Holdings Breakdowns
Virtus LifeSci Biotech Clinical Trials ETF's Top Stock Picks
View Full List
Ticker | | Company | Date | Action | Impact % | Price Range | Price | Price Change from Avrg% | Comment | Current Shares | Share Change |
---|---|---|---|---|---|---|---|---|---|---|---|
VKTX | Viking Therapeutics Inc | 2024-07-31 | Reduce | -2.16% | 47.39 ($59.68) 80.2 | $74.52 | 24.87% | Reduce -61.47% | 1,738 | -2,773 | |
RNA | Avidity Biosciences Inc | 2024-07-31 | Reduce | -2.02% | 25.39 ($35.49) 48.14 | $45.72 | 28.83% | Reduce -79.01% | 2,265 | -8,524 | |
IBRX | ImmunityBio Inc | 2024-07-31 | Sold Out | -1.67% | 5.15 ($6.64) 9.15 | $6.17 | -7.08% | Sold Out | 0 | -21,290 | |
CGEM | Cullinan Therapeutics Inc | 2024-07-31 | Reduce | -1.60% | 16.03 ($21.02) 29.35 | $16.16 | -23.12% | Reduce -59.21% | 4,153 | -6,028 | |
GERN | Geron Corp | 2024-07-31 | Sold Out | -1.51% | 3.32 ($4.27) 5.09 | $4.22 | -1.17% | Sold Out | 0 | -39,205 | |
VERA | Vera Therapeutics Inc | 2024-07-31 | Reduce | -1.34% | 33.72 ($37.85) 45.54 | $47.34 | 25.07% | Reduce -58.89% | 2,420 | -3,466 | |
LBPH | Longboard Pharmaceuticals Inc | 2024-07-31 | New Buy | +1.33% | 17.55 ($25.39) 39.5 | $59.68 | 135.05% | New holding | 4,538 | 4,538 | |
IOVA | Iovance Biotherapeutics Inc | 2024-07-31 | Sold Out | -1.30% | 7.28 ($9.25) 13.98 | $11.04 | 19.35% | Sold Out | 0 | -11,237 | |
ERAS | Erasca Inc | 2024-07-31 | New Buy | +1.15% | 1.85 ($2.47) 3.28 | $2.65 | 7.27% | New holding | 41,526 | 41,526 | |
DYN | Dyne Therapeutics Inc | 2024-07-31 | Reduce | -1.15% | 25.65 ($34.31) 44.53 | $30.85 | -10.08% | Reduce -63.32% | 2,687 | -4,639 |
Virtus LifeSci Biotech Clinical Trials ETF Total Holding History ($B)
Virtus LifeSci Biotech Clinical Trials ETF's Asset Allocation
Virtus LifeSci Biotech Clinical Trials ETF Past Portfolios
Portfolio Date | Number of Stocks | New Stocks | Total Value ($Mil) | Q/Q Turnover |
---|---|---|---|---|
Top Ranked Articles
- 1
Virtus LifeSci Biotech Clinical Trials ETF's Hypothetical Growth since 2024-07-31
Virtus LifeSci Biotech Clinical Trials ETF's Yearly Returns
Year | Portfolio % | % | Excess Gain % |
---|
Virtus LifeSci Biotech Clinical Trials ETF's Holdings Heat Map
Size field:
Virtus LifeSci Biotech Clinical Trials ETF's Holdings Bubble Chart
Virtus LifeSci Biotech Clinical Trials ETF News
- 1
Discussions on Virtus LifeSci Biotech Clinical Trials ETF
No discussions yet.